0001415889-24-016995.txt : 20240614
0001415889-24-016995.hdr.sgml : 20240614
20240614180009
ACCESSION NUMBER: 0001415889-24-016995
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240614
FILED AS OF DATE: 20240614
DATE AS OF CHANGE: 20240614
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Eldridge George A
CENTRAL INDEX KEY: 0001413006
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40544
FILM NUMBER: 241046286
MAIL ADDRESS:
STREET 1: C/O TARGANTA THERAPEUTICS CORPORATION
STREET 2: 222 THIRD STREET SUITE 2300
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aerovate Therapeutics, Inc.
CENTRAL INDEX KEY: 0001798749
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 831377888
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 930 WINTER STREET
STREET 2: SUITE M-500
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-443-2400
MAIL ADDRESS:
STREET 1: 930 WINTER STREET
STREET 2: SUITE M-500
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
form4-06142024_060606.xml
X0508
4
2024-06-14
0001798749
Aerovate Therapeutics, Inc.
AVTE
0001413006
Eldridge George A
C/O AEROVATE THERAPEUTICS, INC.
930 WINTER STREET, SUITE M-500
WALTHAM
MA
02451
false
true
false
false
SEE REMARKS
1
Common Stock
2024-06-14
4
M
0
15000
2.14
A
20022
D
Common Stock
2024-06-14
4
S
0
15000
25.03
D
5022
D
Stock Option (Right to Buy)
2.14
2024-06-14
4
M
0
15000
0
D
2031-04-01
Common Stock
15000
28763
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023.
Includes 3,062 shares purchased under the Issuer's 2021 Employee Stock Purchase Plan on April 30, 2024 in a transaction that is exempt under Rule 16b-3(c) and 16b3(d).
A total of 98,676 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter.
Officer Title: Chief Financial Officer and Treasurer
/s/ George A. Eldridge
2024-06-14